Results 111 to 120 of about 619,328 (341)
Annals of Clinical and Translational Neurology, EarlyView.
Majid Khalilizad +4 more
wiley +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Recurrent high‐grade gliomas have a poor prognosis and limited therapeutic options. This study aimed to evaluate the safety and efficacy of SYHA1813, a dual inhibitor of VEGFR and CSF1R, in patients with recurrent high‐grade gliomas.
Zhuang Kang +16 more
wiley +1 more source
Undergraduate clinical neurosciences programme development: A consumer-based evaluation [PDF]
, 1987 R F Gledhill
openalex +1 more source
Advances in neuroscience [PDF]
Science Advances, 2017 Kevin S. LaBar The burgeoning field of neuroscience is at an important nexus of discovery. The pace of innovation is accelerating along with increased curiosity about how the most mysterious organ of the body works. Emerging technologies, such as optogenetics, permit an inquiry into brain function at unprecedented levels of detail and sophistication.
openaire +3 more sources
Durability of Response to B‐Cell Maturation Antigen‐Directed mRNA Cell Therapy in Myasthenia Gravis
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective We report the 12‐month follow‐up outcomes from a Phase 2 clinical trial (NCT04146051) evaluating Descartes‐08, a BCMA‐directed RNA chimeric antigen receptor T‐cell (rCAR‐T) therapy for refractory generalized myasthenia gravis (MG).
Nizar Chahin +10 more
wiley +1 more source
Pioneers in Neurosciences: The Sherrington Era [PDF]
, 1986 William T. Gibson
openalex +1 more source
Modern neuroscience and near-death experiences: Expectancies and implications. Comments on "A neurobiological model for near-death experiences". [PDF]
, 1989 Michael A. Persinger +2 more
openalex +1 more source
BiomimeticsIn the context of socio-technical systems, traditional engineering approaches are inadequate, calling for a fundamental change in perspective. A different approach encourages viewing socio-technical systems as complex living entities rather than through ...
Andrea Falegnami +3 more
doaj +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Autosomal dominant progranulin (GRN) pathogenic variants are a genetic cause of frontotemporal lobar degeneration. Though clinical trials for GRN‐related therapies are underway, there is an unmet need for biomarkers that can predict symptom onset and track disease progression.
Taru M. Flagan +46 more
wiley +1 more source